Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Doctors, pharmacists and social workers urge restriction on insurer-mandated 'white bagging'
Summary
Multiple proponent witnesses told the House Insurance Committee that insurer- or PBM-mandated white bagging — shipping patient-specific specialty drugs directly to physician offices — risks patient safety, causes treatment delays and creates financial waste; witnesses cited inventory losses, frequent dose changes and potential premium impacts.
Physicians, oncology pharmacists and social workers urged the House Insurance Committee to support House Bill 682, which would prohibit insurer- or PBM-mandated "white bagging" for physician-administered medications.
Dr. Randy Drosik, a hematologist-oncologist, said white bagging inserts extra layers into the drug supply chain, increases the risk of error and can force patients to return for treatment if a pre-shipped medicine no longer matches their needs. "I can take away an entire week of your life in six months quite easily," Dr. Drosik said, describing that roughly 25 percent of patients may need dose adjustments…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
